A national survey shows how GLP-1–associated weight loss is driving facial volume loss, laxity, and wrinkles—and why fillers and neuromodulators anchor treatment for this growing patient group. Plastic Surgery Practice talks to one of the study's authors to break down the findings and what they mean for treatment planning in today’s aesthetic practice.